Mitchell Kapoor
Stock Analyst at HC Wainwright & Co.
(3.41)
# 2,619
Out of 5,131 analysts
334
Total ratings
41.94%
Success rate
6.14%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Mitchell Kapoor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRSP CRISPR Therapeutics AG | Maintains: Buy | $65 → $80 | $53.84 | +48.59% | 5 | Aug 7, 2025 | |
| HALO Halozyme Therapeutics | Maintains: Buy | $72 → $75 | $72.47 | +3.49% | 37 | Aug 6, 2025 | |
| IONS Ionis Pharmaceuticals | Maintains: Buy | $50 → $65 | $80.30 | -19.05% | 5 | Jul 31, 2025 | |
| ALMS Alumis | Reiterates: Buy | $14 | $19.56 | -28.43% | 13 | Jul 25, 2025 | |
| KRRO Korro Bio | Reiterates: Buy | $100 | $9.50 | +952.63% | 13 | Jul 24, 2025 | |
| ORKA Oruka Therapeutics | Reiterates: Buy | $45 | $27.86 | +61.52% | 6 | Jul 23, 2025 | |
| LEGN Legend Biotech | Reiterates: Buy | $75 | $23.60 | +217.80% | 39 | Jul 17, 2025 | |
| TYRA Tyra Biosciences | Reiterates: Buy | $30 | $29.31 | +2.35% | 20 | Jul 1, 2025 | |
| SMMT Summit Therapeutics | Reiterates: Buy | $44 | $19.68 | +123.58% | 14 | Jul 1, 2025 | |
| SRPT Sarepta Therapeutics | Downgrades: Sell | $40 → $10 | $23.83 | -58.04% | 14 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1 → $10 | $24.55 | -59.27% | 13 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $10.38 | +189.02% | 4 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $125 | $7.13 | +1,653.16% | 17 | Jun 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $15 | $16.95 | -11.50% | 1 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $1.31 | +281.68% | 1 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $4 → $5 | $8.32 | -39.90% | 7 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $4.35 | +14.94% | 10 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $15 | $10.54 | +42.31% | 8 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $45 | $17.92 | +151.12% | 15 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3 | $2.07 | +44.93% | 1 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $8.20 | +387.80% | 17 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.71 | - | 20 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $7 | $1.79 | +291.06% | 9 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $5 → $3 | $5.12 | -41.41% | 6 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $2 | $1.94 | +3.09% | 16 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $1.40 | +542.86% | 15 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $5.19 | +189.02% | 2 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4,520,000 → $68,930,000 | $0.79 | +8,725,316,355.70% | 2 | Sep 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $3.76 | - | 4 | Jun 2, 2023 |
CRISPR Therapeutics AG
Aug 7, 2025
Maintains: Buy
Price Target: $65 → $80
Current: $53.84
Upside: +48.59%
Halozyme Therapeutics
Aug 6, 2025
Maintains: Buy
Price Target: $72 → $75
Current: $72.47
Upside: +3.49%
Ionis Pharmaceuticals
Jul 31, 2025
Maintains: Buy
Price Target: $50 → $65
Current: $80.30
Upside: -19.05%
Alumis
Jul 25, 2025
Reiterates: Buy
Price Target: $14
Current: $19.56
Upside: -28.43%
Korro Bio
Jul 24, 2025
Reiterates: Buy
Price Target: $100
Current: $9.50
Upside: +952.63%
Oruka Therapeutics
Jul 23, 2025
Reiterates: Buy
Price Target: $45
Current: $27.86
Upside: +61.52%
Legend Biotech
Jul 17, 2025
Reiterates: Buy
Price Target: $75
Current: $23.60
Upside: +217.80%
Tyra Biosciences
Jul 1, 2025
Reiterates: Buy
Price Target: $30
Current: $29.31
Upside: +2.35%
Summit Therapeutics
Jul 1, 2025
Reiterates: Buy
Price Target: $44
Current: $19.68
Upside: +123.58%
Sarepta Therapeutics
Jun 25, 2025
Downgrades: Sell
Price Target: $40 → $10
Current: $23.83
Upside: -58.04%
Jun 24, 2025
Maintains: Neutral
Price Target: $1 → $10
Current: $24.55
Upside: -59.27%
Jun 16, 2025
Reiterates: Buy
Price Target: $30
Current: $10.38
Upside: +189.02%
Jun 5, 2025
Reiterates: Buy
Price Target: $125
Current: $7.13
Upside: +1,653.16%
Jun 2, 2025
Assumes: Buy
Price Target: $15
Current: $16.95
Upside: -11.50%
Jun 2, 2025
Initiates: Buy
Price Target: $5
Current: $1.31
Upside: +281.68%
May 27, 2025
Upgrades: Buy
Price Target: $4 → $5
Current: $8.32
Upside: -39.90%
May 20, 2025
Reiterates: Buy
Price Target: $5
Current: $4.35
Upside: +14.94%
May 16, 2025
Maintains: Buy
Price Target: $23 → $15
Current: $10.54
Upside: +42.31%
May 13, 2025
Maintains: Buy
Price Target: $50 → $45
Current: $17.92
Upside: +151.12%
Apr 28, 2025
Initiates: Buy
Price Target: $3
Current: $2.07
Upside: +44.93%
Apr 9, 2025
Reiterates: Buy
Price Target: $40
Current: $8.20
Upside: +387.80%
Apr 9, 2025
Downgrades: Neutral
Price Target: n/a
Current: $0.71
Upside: -
Apr 3, 2025
Maintains: Buy
Price Target: $14 → $7
Current: $1.79
Upside: +291.06%
Apr 3, 2025
Maintains: Neutral
Price Target: $5 → $3
Current: $5.12
Upside: -41.41%
Apr 3, 2025
Maintains: Buy
Price Target: $5 → $2
Current: $1.94
Upside: +3.09%
Apr 3, 2025
Reiterates: Buy
Price Target: $9
Current: $1.40
Upside: +542.86%
Mar 24, 2025
Reiterates: Buy
Price Target: $15
Current: $5.19
Upside: +189.02%
Sep 6, 2023
Maintains: Buy
Price Target: $4,520,000 → $68,930,000
Current: $0.79
Upside: +8,725,316,355.70%
Jun 2, 2023
Reiterates: Neutral
Price Target: n/a
Current: $3.76
Upside: -